The aim of this invention was to evaluate all synthesized compounds on different kinases pathways signaling (p38, but also Raf, VEGFR-2, VEGFR-3, PDGFR-beta, Flt-3), all involved in ongoing cancer, in cancer progression, and in the angiogenesis process. The gene discussed is KDR; the disease is cancer.